WEKO3
アイテム
{"_buckets": {"deposit": "3f311aec-ab60-4a9c-a242-f8f747834202"}, "_deposit": {"created_by": 1, "id": "69026", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "69026"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00069026", "sets": ["28"]}, "author_link": ["677450", "677447", "677442", "677444", "677452", "677451", "677448", "677449", "677443", "677445", "677446"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2007-07-12", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Heat-shock protein 90 (Hsp90) is a ubiquitous molecular chaperone protein, which is related to the stabilization and activation of various cell cycle checkpoints and signal transduction proteins. An effective Hsp90 inhibitor 17-AAG has now entered clinical trials. Insulin-like growth factor I receptor (IGF-IR) over-expressed HeLa cells (HeLa-IGF-IR) exhibit a radioresistant phenotype and are difficult to be treated with radio-therapy. We studied the radio-sensitization effects of 17-AAG in HeLa-IGF-IR cells. After pretreatment with 17-AAG for 24 hours, characteristics of irradiated cells were examined by colony-forming assay, MTT assay, western blotting, and immunostaining. 150nM of 17-AAG pretreatment significantly radio-sensitized HeLa-IGF-IR cells, but this sensitization was not observed with non-transfected HeLa cells. The protein expression of PARP after irradiation was reduced with 17-AAG pretreatment, indicating an increase in apoptosis formation. Irradiation with 17-AAG pretreatment in HeLa-IGF-IR cells led to reduction in cell growth kinetics when compared to HeLa cells. The downstream pathways of IGF-IR (PI3-K/Akt and Raf/MEK/ERK pathways, proliferation signal pathways) were inhibited by 17-AAG treatment, and more cells were led to apoptosis. We also used the tumor xenografts model using SQ5 lung carcinoma cells to examine the antitumor effect of 17-AAG in vivo. The combined treatment with 17-AAG (80mg/kg, 1-3 times/week, i.p.) and 8 Gy gamma-rays significantly inhibited tumor growth. 17AAG treatment would be a useful method for certain radio-resistant tumor cells.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "13th International Congress of Radiation Research", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yu, Dong"}], "nameIdentifiers": [{"nameIdentifier": "677442", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sekine, Emiko"}], "nameIdentifiers": [{"nameIdentifier": "677443", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ninomiya, Yasuharu"}], "nameIdentifiers": [{"nameIdentifier": "677444", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fujimori, Akira"}], "nameIdentifiers": [{"nameIdentifier": "677445", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okayasu, Ryuichi"}], "nameIdentifiers": [{"nameIdentifier": "677446", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "677447", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "于 冬", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "677448", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "関根 絵美子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "677449", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "二宮 康晴", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "677450", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤森 亮", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "677451", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡安 隆一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "677452", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Radio-sensitization by 17AAG in human tumor cells", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Radio-sensitization by 17AAG in human tumor cells"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/69026", "pubdate": {"attribute_name": "公開日", "attribute_value": "2007-07-17"}, "publish_date": "2007-07-17", "publish_status": "0", "recid": "69026", "relation": {}, "relation_version_is_last": true, "title": ["Radio-sensitization by 17AAG in human tumor cells"], "weko_shared_id": -1}
Radio-sensitization by 17AAG in human tumor cells
https://repo.qst.go.jp/records/69026
https://repo.qst.go.jp/records/6902646ec66b9-e236-40a7-ba79-5dc2dd0fe32c
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2007-07-17 | |||||
タイトル | ||||||
タイトル | Radio-sensitization by 17AAG in human tumor cells | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Yu, Dong
× Yu, Dong× Sekine, Emiko× Ninomiya, Yasuharu× Fujimori, Akira× Okayasu, Ryuichi× et.al× 于 冬× 関根 絵美子× 二宮 康晴× 藤森 亮× 岡安 隆一 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Heat-shock protein 90 (Hsp90) is a ubiquitous molecular chaperone protein, which is related to the stabilization and activation of various cell cycle checkpoints and signal transduction proteins. An effective Hsp90 inhibitor 17-AAG has now entered clinical trials. Insulin-like growth factor I receptor (IGF-IR) over-expressed HeLa cells (HeLa-IGF-IR) exhibit a radioresistant phenotype and are difficult to be treated with radio-therapy. We studied the radio-sensitization effects of 17-AAG in HeLa-IGF-IR cells. After pretreatment with 17-AAG for 24 hours, characteristics of irradiated cells were examined by colony-forming assay, MTT assay, western blotting, and immunostaining. 150nM of 17-AAG pretreatment significantly radio-sensitized HeLa-IGF-IR cells, but this sensitization was not observed with non-transfected HeLa cells. The protein expression of PARP after irradiation was reduced with 17-AAG pretreatment, indicating an increase in apoptosis formation. Irradiation with 17-AAG pretreatment in HeLa-IGF-IR cells led to reduction in cell growth kinetics when compared to HeLa cells. The downstream pathways of IGF-IR (PI3-K/Akt and Raf/MEK/ERK pathways, proliferation signal pathways) were inhibited by 17-AAG treatment, and more cells were led to apoptosis. We also used the tumor xenografts model using SQ5 lung carcinoma cells to examine the antitumor effect of 17-AAG in vivo. The combined treatment with 17-AAG (80mg/kg, 1-3 times/week, i.p.) and 8 Gy gamma-rays significantly inhibited tumor growth. 17AAG treatment would be a useful method for certain radio-resistant tumor cells. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 13th International Congress of Radiation Research | |||||
発表年月日 | ||||||
日付 | 2007-07-12 | |||||
日付タイプ | Issued |